ivgtt

All patients underwent IVGTT at baseline and1 month and6 months after surgery .

所有患者在术前（基线）、术后1月、术后6月接受IVGTT检查。

Objective To evaluate the curative effect of urokinase ivgtt thrombolysis for the treatment of acute cerebral infarction and to explore the mechanism .

目的评估急性脑梗塞尿激酶静脉溶栓治疗的疗效，并探讨作用机制。

The curve and K value of the IVGTT after transplant were similar to the normal ones ( 2.802,2.3 , P > 0.05 ) .

移植组糖耐量曲线与正常大鼠相似，K值与正常非糖尿病大鼠差异无显著性（2.802,2.3，P>0.05）。

The intravenous glucose tolerance test ( IVGTT ) was performed to evaluate the dose-effective relationship of Liraglutide .

采用静脉葡萄糖耐量试验（IVGTT）评价Liraglutide量效关系。

Leucovorin ( CF ) 200 mg / m 2 , ivgtt , from day 1 to day 5 ;

醛氢叶酸（CF）200mgm2，静滴，第1～5天；

The 40 cases in the control group were treated with the CHOP regimen , i.e. CTX 750mg / m ~ 2 ivgtt , dl ;

对照组为CHOP方案：CTX750mg/m~2静脉注射，d1；

A total of 65 patients were randomly divided into two groups : 35 patients in treatment group received LL 0.2 bid po and NS 0.2 ~ 0.3g , ivgtt qd ;

65例病人随机分为治疗组35例，左氧氟沙星片0.2g，bid，奈替米星针0.2～0.3g，qd；

Methods The intravenous glucose tolerance tests ( IVGTT ) were measured on 315 first-diagnosed type 2 diabetic patients , and at 0,1,2,3,10,30,60,120,180 minutes , the blood glucose , insulin level and others were noted down .

方法对315例初诊为2型糖尿病的患者行静脉葡萄糖耐量试验（IVGTT），测定0、1、2、3、10、30、60、120、180分钟血糖、胰岛素及其他临床指标。

The control group ( 31 cases ) were given only liver protecting drugs , ivgtt , total 30 days . Before and after treatment , patients ' blood was examined for serum HBV markers , HBV-DNA and liver function changes .

对照组31例，仅给常规护肝药物、静脉滴注，共30d，检测治疗前后患者血清乙肝三系，HBV-DNA及肝功能变化情况。

Methods 100 patients with arrhythmias in AMI were divided randomly into two groups , treatment group : using potassium magnesium aspartate 50ml + 10 % G · S 500ml + Insulin 8u ivgtt qd .

方法将100例急性心肌梗死心律失常患者分为2组，治疗组：门冬氨酸钾镁50ml+10%G·S500ml+普通胰岛素8Uivgttqd；